Technical Analysis for BHC - Bausch Health Companies Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Gapped Up | Strength | 0.00% | |
Crossed Above 20 DMA | Bullish | 1.96% | |
Inside Day | Range Contraction | 1.96% | |
Fell Below 20 DMA | Bearish | 3.19% | |
Gapped Down | Weakness | 3.19% | |
Shooting Star Candlestick | Bearish | 1.08% | |
20 DMA Support | Bullish | 2.07% | |
NR7 | Range Contraction | 2.07% | |
NR7-2 | Range Contraction | 2.07% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 11 hours ago |
Up 2% | about 11 hours ago |
Up 1% | about 16 hours ago |
20 DMA Support | about 16 hours ago |
10 DMA Support | about 16 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/02/2024
Bausch Health Companies Inc. Description
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Organ Systems Laser Eye Pharmaceutical Products Gastrointestinal Medical Device S&P/Tsx 60 Index Health Products Dermatology Psoriasis Specialty Drugs Gastroenterology Ulcerative Colitis Ulcer Colitis Atopic Dermatitis Acne Dermatitis Diarrhea Contact Lens Irritable Bowel Syndrome Generic Pharmaceutical Wrinkle Generic Pharmaceuticals Hair Removal Over The Counter Products Actinic Keratosis Keratosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 10.145 |
52 Week Low | 5.5703 |
Average Volume | 2,364,800 |
200-Day Moving Average | 8.07 |
50-Day Moving Average | 8.63 |
20-Day Moving Average | 9.23 |
10-Day Moving Average | 9.26 |
Average True Range | 0.28 |
RSI (14) | 59.68 |
ADX | 34.6 |
+DI | 29.65 |
-DI | 14.95 |
Chandelier Exit (Long, 3 ATRs) | 9.05 |
Chandelier Exit (Short, 3 ATRs) | 9.16 |
Upper Bollinger Bands | 9.78 |
Lower Bollinger Band | 8.67 |
Percent B (%b) | 0.64 |
BandWidth | 12.00 |
MACD Line | 0.20 |
MACD Signal Line | 0.25 |
MACD Histogram | -0.0484 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 9.72 | ||||
Resistance 3 (R3) | 9.68 | 9.53 | 9.66 | ||
Resistance 2 (R2) | 9.53 | 9.45 | 9.55 | 9.64 | |
Resistance 1 (R1) | 9.46 | 9.39 | 9.50 | 9.49 | 9.62 |
Pivot Point | 9.31 | 9.31 | 9.33 | 9.33 | 9.31 |
Support 1 (S1) | 9.23 | 9.22 | 9.27 | 9.27 | 9.14 |
Support 2 (S2) | 9.08 | 9.17 | 9.10 | 9.12 | |
Support 3 (S3) | 9.01 | 9.08 | 9.10 | ||
Support 4 (S4) | 9.04 |